Provided by Tiger Fintech (Singapore) Pte. Ltd.

ImmunityBio, Inc.

2.47
-0.0100-0.40%
Post-market: 2.45-0.0200-0.81%19:58 EDT
Volume:4.71M
Turnover:11.52M
Market Cap:2.11B
PE:-3.99
High:2.50
Open:2.47
Low:2.39
Close:2.48
Loading ...

ImmunityBio Price Target Maintained With a $8.00/Share by HC Wainwright & Co.

Dow Jones
·
16 Apr

ImmunityBio Completes FDA License Application Submissions

MT Newswires Live
·
15 Apr

BRIEF-Immunitybio Announces FDA Submissions Of Supplemental BLA For Nmibc Papillary Disease And For Expanded Access Of Anktiva®To Treat Lymphopenia

Reuters
·
15 Apr

ImmunityBio Is Maintained at Buy by D. Boral Capital

Dow Jones
·
15 Apr

Immunitybio Announces FDA Submissions of Supplemental Bla for Nmibc Papillary Disease and for Expanded Access of Anktiva® to Treat Lymphopenia

THOMSON REUTERS
·
15 Apr

ImmunityBio Announces FDA Submissions of Supplemental BLA for NMIBC Papillary Disease and for Expanded Access of ANKTIVA® to Treat Lymphopenia

Business Wire
·
15 Apr

ImmunityBio Is Maintained at Buy by D. Boral Capital

Dow Jones
·
09 Apr

ImmunityBio Launches $75 Million Registered Direct Offering

MT Newswires Live
·
08 Apr

Immunitybio Announces Execution of $75 Million Equity Financing With an Institutional Investor

THOMSON REUTERS
·
08 Apr

ImmunityBio Announces Execution of $75 Million Equity Financing with an Institutional Investor

Business Wire
·
08 Apr

Immunitybio to Host Key Opinion Leader and Investor Meeting to Provide Updates on Clinical Programs and Anktiva Commercial Launch

THOMSON REUTERS
·
07 Apr

ImmunityBio to Host Key Opinion Leader and Investor Meeting to Provide Updates on Clinical Programs and ANKTIVA Commercial Launch

Business Wire
·
07 Apr

Exploring US High Growth Tech Stocks In April 2025

Simply Wall St.
·
03 Apr

ImmunityBio Is Maintained at Buy by D. Boral Capital

Dow Jones
·
31 Mar

ImmunityBio to Host Investor Day

Business Wire
·
26 Mar

ImmunityBio Price Target Maintained With a $8.00/Share by HC Wainwright & Co.

Dow Jones
·
14 Mar

ImmunityBio Is Maintained at Buy by D. Boral Capital

Dow Jones
·
13 Mar

ImmunityBio Partner US Urology Begins Administering rBCG to Address Tice BCG Shortage

MT Newswires Live
·
13 Mar

Top Growth Companies With Insider Stakes For March 2025

Simply Wall St.
·
07 Mar

BUZZ-U.S. STOCKS ON THE MOVE-CoreCivic, Teladoc, Dynavax

Reuters
·
06 Mar